Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Comment by snuff133on Mar 09, 2021 9:00am
236 Views
Post# 32750927

RE:news

RE:newsAttached is a news release.  Here is some background:

1.      All medical devices have to be cleared, licensed, certified..lots of different “words” for regulatory approvals to sell the device in different countries.
2.      The company has these approvals in Canada, USA, Europe and China, but still needs to maintain a comprehensive Quality Assurance System (QAS), which is audited regularly. 
3.      In addition, we have established our own manufacturing facility for the VMS+3.0 and that too has been inspected every 3 months for a year to make sure it is being run in accordance with North American regulations.  Since we have passed all 4 inspections this year, we can go to less frequent inspections in the future.
4.      The regulations also evolve over so we must also change how we do things to remain compliant.
5.      It is a lot of paperwork and training of staff to remain in compliance with all the regulations, but it is necessary to maintain our approvals as well as to maintain the safety and quality of our products.   
6.      The recent QAS audit was a comprehensive one with a complete review of our technical file in Europe.  It took many months to complete, but it is now not needed again for some years.
7.      I have elected to tell you all about these successful audits so you will understand how hard the team is working and how successful it has been maintaining our status in spite of working from home and COVID limitations.

Thank you for your interest and support as we continue our mission to improve cardiac diagnostics and care world-wide for everyone and especially for children.

Regards,

Dr. George Adams ICD.D
Executive-Chairman
<< Previous
Bullboard Posts
Next >>